NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
04 Noviembre 2022 - 2:03PM
NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device
company focused on transforming the lives of people living with
epilepsy, today announced it will be participating in the upcoming
4th Annual Wolfe Research Healthcare Conference. Management is
scheduled to present on Wednesday, November 16th at 2:40 p.m.
Eastern Time. A live webcast of this event, as well as an archived
recording, will be available on the “Investors” section of the
company’s website at: https://investors.neuropace.com. The webcasts
will be archived and available for replay for at least 90 days
after the event.
About NeuroPace, Inc. Based in
Mountain View, Calif., NeuroPace is a commercial-stage medical
device company focused on transforming the lives of people living
with epilepsy by reducing or eliminating the occurrence of
debilitating seizures. Its novel and differentiated RNS System is
the first and only commercially available, brain-responsive
platform that delivers personalized, real-time treatment at the
seizure source. This platform can drive a better standard of care
for patients living with drug-resistant epilepsy and has the
potential to offer a more personalized solution and improved
outcomes to the large population of patients suffering from other
brain disorders.
Investor Contact:Philip
TaylorGilmartin Groupinvestors@neuropace.com
Neuropace (NASDAQ:NPCE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Neuropace (NASDAQ:NPCE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024